Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -46.66%1.73B | 63.86%3.25B | 32.09%1.98B | -66.44%1.5B | 3,480.80%4.48B | -95.54%125M | -34.26%2.8B | 387.99%4.27B | 121.27%874M | -83.98%395M |
Net profit before non-cash adjustment | -4.76%2.84B | 3.61%2.98B | 32.72%2.88B | -13.03%2.17B | 7.08%2.5B | 13.27%2.33B | 13.27%2.06B | 20.58%1.82B | 7.73%1.51B | 6.64%1.4B |
Total adjustment of non-cash items | -154.08%-245M | 239.81%453M | -180.80%-324M | 324.02%401M | -135.53%-179M | -151.35%-76M | 428.89%148M | -4.65%-45M | -150.00%-43M | 186.00%86M |
-Depreciation and amortization | -6.67%224M | -3.61%240M | 2.05%249M | 31.18%244M | -3.13%186M | -13.51%192M | -6.33%222M | 2.16%237M | 26.09%232M | 6.36%184M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -197.50%-117M | 248.15%120M |
-Share of associates | -126.92%-295M | 36.59%-130M | -12.02%-205M | -2.81%-183M | 9.18%-178M | -18.07%-196M | -0.61%-166M | -122.97%-165M | 3.90%-74M | -26.23%-77M |
-Disposal profit | ---27M | --0 | -6,900.00%-68M | 100.59%1M | -129.73%-170M | ---74M | --0 | ---202M | --0 | -150.00%-15M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -11.29%-69M | ---62M |
-Other non-cash items | -142.86%-147M | 214.33%343M | -188.50%-300M | 2,094.12%339M | -950.00%-17M | -97.83%2M | 8.24%92M | 666.67%85M | 76.56%-15M | 67.51%-64M |
Changes in working capital | -353.68%-862M | 66.61%-190M | 46.77%-569M | -149.54%-1.07B | 201.31%2.16B | -457.38%-2.13B | -76.08%596M | 523.09%2.49B | 45.91%-589M | -186.77%-1.09B |
-Change in receivables | -133.69%-220M | 156.78%653M | -35.29%-1.15B | -141.65%-850M | 238.37%2.04B | -315.49%-1.48B | -107.60%-355M | -130.59%-171M | 184.19%559M | -276.60%-664M |
-Change in inventory | -1,071.26%-1.02B | -107.32%-87M | 127.59%1.19B | 317.50%522M | 86.39%-240M | -363.53%-1.76B | -69.70%669M | 564.84%2.21B | -501.27%-475M | -108.26%-79M |
-Change in prepaid assets | ---- | ---- | ---- | ---- | -333.33%-14M | -57.14%6M | 123.33%14M | -158.82%-60M | --102M | ---- |
-Change in payables | 141.93%392M | -223.03%-935M | 190.69%760M | -143.60%-838M | -135.72%-344M | 618.66%963M | -69.61%134M | 154.18%441M | -194.93%-814M | -338.10%-276M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 164.41%38M | ---59M |
-Provision for loans, leases and other losses | -187.80%-144M | 360.32%164M | -6.78%-63M | -110.71%-59M | -264.71%-28M | 121.52%17M | -194.05%-79M | --84M | ---- | ---- |
-Changes in other current assets | 760.00%129M | 101.15%15M | -935.90%-1.3B | -79.00%156M | 509.02%743M | -42.72%122M | 2,230.00%213M | -1,100.00%-10M | 109.09%1M | 21.43%-11M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 16.67%-20M | 4.00%-24M | 10.71%-25M | 12.50%-28M | 5.88%-32M | 12.82%-34M | 22.00%-39M | 19.35%-50M | -16.98%-62M | 14.52%-53M |
Interest received (cash flow from operating activities) | 19.51%49M | 13.89%41M | -2.70%36M | -22.92%37M | 2.13%48M | 27.03%47M | 15.63%37M | -5.88%32M | -57.50%34M | 122.22%80M |
Tax refund paid | -44.49%-1.05B | 19.15%-726M | -42.54%-898M | 13.82%-630M | -22.24%-731M | 4.63%-598M | -53.30%-627M | 46.33%-409M | -61.78%-762M | -18.05%-471M |
Other operating cash inflow (outflow) | 175.00%3M | 98.10%-4M | -3,616.67%-211M | -50.00%6M | 12M | 0 | 0.00%-1M | 50.00%-1M | -300.00%-2M | 1M |
Operating cash flow | -71.75%717M | 186.46%2.54B | -0.11%886M | -76.49%887M | 920.22%3.77B | -121.16%-460M | -43.34%2.17B | 4,579.27%3.84B | 270.83%82M | -102.35%-48M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -113.64%-47M | 43.59%-22M | 58.95%-39M | -58.33%-95M | 42.86%-60M | 70.09%-105M | 39.79%-351M | -302.07%-583M | -1,135.71%-145M | 216.67%14M |
Net intangibles purchase and sale | 41.18%-10M | 34.62%-17M | 72.04%-26M | 24.39%-93M | -19.42%-123M | ---103M | --0 | 46.15%-7M | 50.00%-13M | 52.73%-26M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---659M | ---- | ---504M |
Net investment product transactions | 148.77%79M | -374.58%-162M | 126.11%59M | -166.28%-226M | 408.96%341M | 149.26%67M | 6.21%-136M | -159.43%-145M | 662.50%244M | 125.81%32M |
Net changes in other investments | 160.00%3M | -600.00%-5M | 200.00%1M | ---1M | ---- | 83.78%-6M | -511.11%-37M | 280.00%9M | -150.00%-5M | -300.00%-2M |
Investing cash flow | 112.14%25M | -4,020.00%-206M | 98.80%-5M | -362.66%-415M | 207.48%158M | 71.95%-147M | 62.17%-524M | -1,809.88%-1.39B | 116.67%81M | -155.79%-486M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -2,533.33%-790M | 95.18%-30M | -257.47%-622M | 115.52%395M | -365.38%-2.55B | 179.13%959M | 45.11%-1.21B | -674.74%-2.21B | -113.26%-285M | 214.80%2.15B |
Net common stock issuance | 105.37%28M | ---521M | --0 | --0 | 100.94%8M | -160.60%-852M | 488.40%1.41B | -1,623.81%-362M | ---21M | ---- |
Cash dividends paid | -22.45%-851M | -45.09%-695M | -5.27%-479M | -4.36%-455M | 1.58%-436M | -25.14%-443M | -105.81%-354M | 0.00%-172M | 0.00%-172M | -1.18%-172M |
Net other fund-raising expenses | -1,400.00%-13M | 108.33%1M | 7.69%-12M | -262.50%-13M | -20.00%8M | 225.00%10M | -700.00%-8M | ---1M | ---- | 50.00%-1M |
Financing cash flow | -30.60%-1.63B | -11.86%-1.25B | -1,424.66%-1.11B | 97.54%-73M | -809.51%-2.97B | -94.05%-326M | 93.88%-168M | -473.85%-2.74B | -124.19%-478M | 196.67%1.98B |
Net cash flow | ||||||||||
Beginning cash position | 24.47%5.53B | -4.96%4.44B | 9.28%4.68B | 29.13%4.28B | -22.03%3.31B | 53.50%4.25B | -9.51%2.77B | -9.34%3.06B | 74.91%3.37B | -9.10%1.93B |
Current changes in cash | -181.32%-884M | 568.53%1.09B | -158.15%-232M | -58.70%399M | 203.54%966M | -162.96%-933M | 609.28%1.48B | 7.62%-291M | -121.84%-315M | 847.15%1.44B |
Effect of exchange rate changes | --0 | --0 | --1M | --0 | ---1M | --0 | --0 | --0 | -133.33%-1M | 200.00%3M |
Cash adjustments other than cash changes | --1M | ---- | 50.00%-1M | ---2M | ---- | 0.00%-1M | ---1M | ---- | --1M | ---- |
End cash Position | -15.97%4.65B | 24.47%5.53B | -4.96%4.44B | 9.28%4.68B | 29.05%4.28B | -21.98%3.32B | 53.50%4.25B | -9.51%2.77B | -9.34%3.06B | 74.91%3.37B |
Free cash flow | -73.59%660M | 204.38%2.5B | 18.30%821M | -80.67%694M | 435.83%3.59B | -158.64%-1.07B | -40.13%1.82B | 4,106.58%3.05B | 37.19%-76M | -106.29%-121M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |